proxyvotesnow.com

Home › Companies › TREACE MEDICAL CONCEPTS INC. › 2023-2024

TREACE MEDICAL CONCEPTS INC. 2023-2024 Proxy Voting Records

Compiled from SEC Form N-PX filings and TREACE MEDICAL CONCEPTS INC.’s Form 8-K, filed 2024-05-22 (Item 5.07 on EDGAR). Page generated 02 October 2026.

  • 8Reported items
  • 162Asset managers
  • 1,246Fund votes
  • 2024-05-21Meeting date

Proxy season: 2023-2024 2024-2025 2025-2026

Explore TREACE MEDICAL CONCEPTS INC. in the interactive database Compare manager voting policies

Official 2023-2024 meeting results reported by TREACE MEDICAL CONCEPTS INC.

These tallies are TREACE MEDICAL CONCEPTS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2024-05-22 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

TREACE MEDICAL CONCEPTS INC. — official shareholder meeting results, meeting held 2024-05-21
Ballot itemForAgainst AbstainWithheldBroker non-votesOutcome
Elect Director: John K. Bakewell 39,111,657---- 9,678,8275,994,650 Majority: yes
Elect Director: Richard W. Mott 40,173,787---- 8,616,6975,994,650 Majority: yes
Elect Director: John T. Treace 44,023,225---- 4,767,2595,994,650 Majority: yes
Proposal 2: Advisory Vote on Executive Compensation 44,766,5614,009,99913,924 --5,994,650 Majority: yes
Proposal 4: Ratification of Selection of Independent Registered Public Accounting Firm 52,692,6492,089,8502,635 --0 Majority: yes

Source: TREACE MEDICAL CONCEPTS INC., Form 8-K, filed with the SEC on 2024-05-22 — read the filing on EDGAR.

How asset managers voted at the TREACE MEDICAL CONCEPTS INC. 2023-2024 meeting

Each item below shows how the 162 asset managers that disclosed a TREACE MEDICAL CONCEPTS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of TREACE MEDICAL CONCEPTS INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. Approval, on an advisory, non- binding basis, of the compensation of the Company's named executive officers.

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Combines 10 wordings of this item as funds reported it.

92% Majority: yes · of votes cast

FOR 92%8%
FOR: 44,766,561AGAINST: 4,009,999

TREACE MEDICAL CONCEPTS INC.’s own tally for this item (“Proposal 2: Advisory Vote on Executive Compensation”): 44,766,561 for, 4,009,999 against, per its Form 8-K filed 2024-05-22 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 62,008,135 outstanding shares: 72% for, 6% against (79% of the company cast a for/against vote).

The 160 asset managers below cast 93% of the shares they voted on this item FOR (42,769,603 for, 3,064,518 against).

FOR 93%
FOR: 42,769,603 (93.3%)AGAINST: 3,064,518 (6.7%)NOT VOTED: 5,000 (0.0%)
Largest asset managers voting on “Approval, on an advisory, non- binding basis, of the compensation of the Company's named executive officers.” at TREACE MEDICAL CONCEPTS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
CIBC Private Wealth Group LLC14,730,1140 00For
Vanguard4,298,8550 00For
BlackRock3,349,54513,265 00For
PERCEPTIVE ADVISORS LLC2,107,6310 00For
ARMISTICE CAPITAL, LLC02,078,999 00Against
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC1,838,7430 00For
State Street1,484,67516,661 00For
TimesSquare Capital Management, LLC1,230,7800 00For
EMERALD MUTUAL FUND ADVISERS TRUST1,229,1280 00For
GEODE CAPITAL MANAGEMENT, LLC976,6360 00For
Fidelity952,9100 00For
EMERALD ADVISERS, LLC876,0810 00For
Soleus Capital Management, L.P.861,6640 00For
WILLIAM BLAIR FUNDS787,7190 00For
NEXT CENTURY GROWTH INVESTORS LLC760,4270 00For
Charles Schwab716,3180 00For
BUFFALO FUNDS677,7330 00For
FINANCIAL INVESTORS TRUST645,7990 00For
Candriam S.C.A.0454,945 00Against
Principal434,1040 00For
Northern Trust400,9342,360 00For
Novo Holdings A/S360,0000 00For
STATE OF WISCONSIN INVESTMENT BOARD326,3350 00For
FORMULA GROWTH LTD323,0690 00For
Invesco276,7140 00For

Showing the 25 largest of 160 asset managers. See all 160 in the interactive database.

2. Approval, on an advisory, non- binding basis, of the frequency of future advisory votes on the compensation of the Company's named executive officers.

SECTION 14A SAY-ON-PAY VOTES

Combines 7 wordings of this item as funds reported it.

100% fund support · no official result

ONE YEAR 76%1 YEAR 19%

The 148 asset managers below cast 100% of the shares they voted on this item FOR (137,892 for, 0 against).

FOR: 137,892 (0.3%)ABSTAIN: 2,078,999 (4.6%)ONE YEAR: 34,613,485 (76.3%)1 YEAR: 8,473,612 (18.7%)THREE YEARS: 31,183 (0.1%)3 YEARS: 6,991 (0.0%)NOT VOTED: 5,000 (0.0%)
Largest asset managers voting on “Approval, on an advisory, non- binding basis, of the frequency of future advisory votes on the compensation of” at TREACE MEDICAL CONCEPTS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
CIBC Private Wealth Group LLC00 00One Year
Vanguard00 00One Year
BlackRock00 00One Year
PERCEPTIVE ADVISORS LLC00 001 Year
ARMISTICE CAPITAL, LLC00 2,078,9990Abstain
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC00 00One Year
State Street00 00One Year
TimesSquare Capital Management, LLC00 00One Year
EMERALD MUTUAL FUND ADVISERS TRUST00 001 Year
GEODE CAPITAL MANAGEMENT, LLC00 00One Year
Fidelity00 00One Year
EMERALD ADVISERS, LLC00 001 Year
Soleus Capital Management, L.P.00 001 Year
WILLIAM BLAIR FUNDS00 00One Year
NEXT CENTURY GROWTH INVESTORS LLC00 00One Year
Charles Schwab00 001 Year
BUFFALO FUNDS00 001 Year
FINANCIAL INVESTORS TRUST00 001 Year
Candriam S.C.A.00 00One Year
Principal00 00One Year
Northern Trust00 001 Year
Novo Holdings A/S00 00One Year
STATE OF WISCONSIN INVESTMENT BOARD00 00One Year
Invesco00 00One Year
MARSHALL WACE, LLP00 001 Year

Showing the 25 largest of 148 asset managers. See all 148 in the interactive database.

3. Election of Directors: John K. Bakewell

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

80% Majority: yes · of votes cast

FOR 80%WITHHELD 20%
FOR: 39,111,657WITHHELD: 9,678,827

TREACE MEDICAL CONCEPTS INC.’s own tally for this item (“Elect Director: John K. Bakewell”): 39,111,657 for, 9,678,827 withheld, per its Form 8-K filed 2024-05-22 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 62,008,135 outstanding shares: 63% for, 16% withheld (79% of the company cast a for/withheld vote).

The 52 asset managers below cast 100% of the shares they voted on this item FOR (10,148,764 for, 0 against).

FOR 79%ABSTAIN 21%
FOR: 10,148,764 (78.7%)ABSTAIN: 2,754,046 (21.3%)
Largest asset managers voting on “Election of Directors: John K. Bakewell” at TREACE MEDICAL CONCEPTS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard4,174,3740 00For
BlackRock1,855,8870 00For
TimesSquare Capital Management, LLC1,230,7800 00For
Fidelity951,4100 00For
WILLIAM BLAIR FUNDS00 787,7190Abstain
BUFFALO FUNDS677,7330 00For
FINANCIAL INVESTORS TRUST00 645,7990Abstain
Principal00 434,1040Abstain
Charles Schwab358,1590 00For
State Street326,9450 8970For
TIAA00 194,1930Abstain
Prudential/PGIM00 154,4950Abstain
GuideStone00 150,6300Abstain
Invesco00 132,3720Abstain
Equitable70,2160 61,0300For
AMG FUNDS108,2500 00For
JPMorgan107,1000 00For
QUANTITATIVE MASTER SERIES LLC80,3960 00For
Grandeur Peak Global Trust55,2790 00For
Nushares ETF Trust00 47,6030Abstain
Lincoln Financial47,5160 00For
Voya00 25,4920Abstain
AIG/SunAmerica00 22,2860Abstain
Global X00 20,7250Abstain
PARADIGM FUNDS20,0000 00For

Showing the 25 largest of 52 asset managers. See all 52 in the interactive database.

4. Election of Directors: Richard W. Mott

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

82% Majority: yes · of votes cast

FOR 82%WITHHELD 18%
FOR: 40,173,787WITHHELD: 8,616,697

TREACE MEDICAL CONCEPTS INC.’s own tally for this item (“Elect Director: Richard W. Mott”): 40,173,787 for, 8,616,697 withheld, per its Form 8-K filed 2024-05-22 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 62,008,135 outstanding shares: 65% for, 14% withheld (79% of the company cast a for/withheld vote).

The 52 asset managers below cast 100% of the shares they voted on this item FOR (9,604,028 for, 0 against).

FOR 74%ABSTAIN 26%
FOR: 9,604,028 (74.4%)ABSTAIN: 3,298,782 (25.6%)
Largest asset managers voting on “Election of Directors: Richard W. Mott” at TREACE MEDICAL CONCEPTS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard4,174,3740 00For
BlackRock00 1,855,8870Abstain
TimesSquare Capital Management, LLC1,230,7800 00For
Fidelity927,7970 23,6130For
WILLIAM BLAIR FUNDS787,7190 00For
BUFFALO FUNDS677,7330 00For
FINANCIAL INVESTORS TRUST00 645,7990Abstain
Principal5,2700 428,8340Abstain
Charles Schwab358,1590 00For
State Street327,8020 400For
TIAA194,1930 00For
Prudential/PGIM00 154,4950Abstain
GuideStone150,6300 00For
Invesco132,3720 00For
Equitable61,0300 70,2160Abstain
AMG FUNDS108,2500 00For
JPMorgan107,1000 00For
QUANTITATIVE MASTER SERIES LLC00 80,3960Abstain
Grandeur Peak Global Trust55,2790 00For
Nushares ETF Trust47,6030 00For
Lincoln Financial47,5160 00For
Voya25,4920 00For
AIG/SunAmerica22,2860 00For
Global X20,7250 00For
PARADIGM FUNDS20,0000 00For

Showing the 25 largest of 52 asset managers. See all 52 in the interactive database.

5. Election of Directors: John T. Treace

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

90% Majority: yes · of votes cast

FOR 90%10%
FOR: 44,023,225WITHHELD: 4,767,259

TREACE MEDICAL CONCEPTS INC.’s own tally for this item (“Elect Director: John T. Treace”): 44,023,225 for, 4,767,259 withheld, per its Form 8-K filed 2024-05-22 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 62,008,135 outstanding shares: 71% for, 8% withheld (79% of the company cast a for/withheld vote).

The 52 asset managers below cast 100% of the shares they voted on this item FOR (11,666,649 for, 0 against).

FOR 90%10%
FOR: 11,666,649 (90.4%)ABSTAIN: 1,236,161 (9.6%)
Largest asset managers voting on “Election of Directors: John T. Treace” at TREACE MEDICAL CONCEPTS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard4,174,3740 00For
BlackRock1,855,8870 00For
TimesSquare Capital Management, LLC1,230,7800 00For
Fidelity951,4100 00For
WILLIAM BLAIR FUNDS787,7190 00For
BUFFALO FUNDS677,7330 00For
FINANCIAL INVESTORS TRUST00 645,7990Abstain
Principal5,2700 428,8340Abstain
Charles Schwab358,1590 00For
State Street327,8020 400For
TIAA194,1930 00For
Prudential/PGIM00 154,4950Abstain
GuideStone150,6300 00For
Invesco132,3720 00For
Equitable131,2460 00For
AMG FUNDS108,2500 00For
JPMorgan107,1000 00For
QUANTITATIVE MASTER SERIES LLC80,3960 00For
Grandeur Peak Global Trust55,2790 00For
Nushares ETF Trust47,6030 00For
Lincoln Financial47,5160 00For
Voya25,4920 00For
AIG/SunAmerica22,2860 00For
Global X20,7250 00For
PARADIGM FUNDS20,0000 00For

Showing the 25 largest of 52 asset managers. See all 52 in the interactive database.

6. RATIFICATION OF THE APPOINTMENT OF GRANT THORNTON LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE YEAR ENDING DECEMBER 31, 2024.

AUDIT-RELATEDMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

96% Majority: yes · of votes cast

FOR 96%
FOR: 52,692,649AGAINST: 2,089,850

TREACE MEDICAL CONCEPTS INC.’s own tally for this item (“Proposal 4: Ratification of Selection of Independent Registered Public Accounting Firm”): 52,692,649 for, 2,089,850 against, per its Form 8-K filed 2024-05-22 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 62,008,135 outstanding shares: 85% for, 3% against (88% of the company cast a for/against vote).

The 52 asset managers below cast 99.9% of the shares they voted on this item FOR (13,026,034 for, 135 against).

FOR 99.9%
FOR: 13,026,034 (100.0%)AGAINST: 135 (0.0%)
Largest asset managers voting on “RATIFICATION OF THE APPOINTMENT OF GRANT THORNTON LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTIN” at TREACE MEDICAL CONCEPTS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard4,174,3740 00For
BlackRock1,855,8870 00For
TimesSquare Capital Management, LLC1,230,7800 00For
Fidelity951,4100 00For
WILLIAM BLAIR FUNDS787,7190 00For
BUFFALO FUNDS677,7330 00For
FINANCIAL INVESTORS TRUST645,7990 00For
Principal434,1040 00For
Charles Schwab358,1590 00For
State Street327,8420 00For
TIAA194,1930 00For
Prudential/PGIM154,4950 00For
GuideStone150,6300 00For
Gabelli143,3590 00For
Invesco132,3720 00For
Equitable131,2460 00For
AMG FUNDS108,2500 00For
JPMorgan107,1000 00For
QUANTITATIVE MASTER SERIES LLC80,3960 00For
Grandeur Peak Global Trust55,2790 00For
Nushares ETF Trust47,6030 00For
Lincoln Financial47,5160 00For
Voya25,4920 00For
AIG/SunAmerica22,2860 00For
Global X20,7250 00For

Showing the 25 largest of 52 asset managers. See all 52 in the interactive database.

7. Advisory Vote on Say on Pay Frequency

SECTION 14A SAY-ON-PAY VOTES

— fund support · no official result

ONE YEAR 100%

No shares were cast for or against this item by the managers below — every disclosed position was an abstention or was not voted.

ONE YEAR: 131,818 (100.0%)
Largest asset managers voting on “Advisory Vote on Say on Pay Frequency” at TREACE MEDICAL CONCEPTS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
JPMorgan00 00One Year
PARADIGM FUNDS00 00One Year
Desjardins Global Asset Management Inc.00 00One Year

8. Approval, on an advisory, non-binding basis, the frequency of future advisory votes on the compensation of the Company's named executive officers

SECTION 14A SAY-ON-PAY VOTES

— fund support · no official result

ONE YEAR 100%

No shares were cast for or against this item by the managers below — every disclosed position was an abstention or was not voted.

ONE YEAR: 13,738 (100.0%)
Largest asset managers voting on “Approval, on an advisory, non-binding basis, the frequency of future advisory votes on the compensation of the” at TREACE MEDICAL CONCEPTS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Orion Porfolio Solutions, LLC00 00One Year
Orion Portfolio Solutions, LLC00 00One Year

Largest TREACE MEDICAL CONCEPTS INC. shareholders voting in 2023-2024

Ranked by the number of TREACE MEDICAL CONCEPTS INC. shares each manager voted on the most widely held ballot item of the 2023-2024 meeting, shown as a share of the 62,008,135 shares outstanding at the time of that meeting.

Top TREACE MEDICAL CONCEPTS INC. shareholders by shares voted, 2023-2024
#Asset manager % of shares outstanding
1CIBC Private Wealth Group LLC 23.76%
2Vanguard 6.93%
3BlackRock 5.42%
4PERCEPTIVE ADVISORS LLC 3.40%
5ARMISTICE CAPITAL, LLC 3.35%
6WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 2.97%
7State Street 2.42%
8TimesSquare Capital Management, LLC 1.98%
9EMERALD MUTUAL FUND ADVISERS TRUST 1.98%
10GEODE CAPITAL MANAGEMENT, LLC 1.58%

Reported TREACE MEDICAL CONCEPTS INC. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

TREACE MEDICAL CONCEPTS INC. beneficial owners on record for the 2023-2024 proxy season
Holder % outstanding Disclosure
BlackRock 5.94% 13F
Vanguard Group 4.41% 13F
Millennium Management 3.29% 13F
JPMorgan Chase 2.60% 13F
State Street 2.02% 13F
Norges Bank 1.62% 13F
Geode Capital 1.59% 13F
Morgan Stanley 1.23% 13F
Northern Trust 0.64% 13F
Charles Schwab 0.58% 13F

Percentages above are of 62,008,135 shares outstanding, as reported by TREACE MEDICAL CONCEPTS INC. on its Form 10-Q dated 2024-05-01 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from TREACE MEDICAL CONCEPTS INC.’s 10-Q dated 2024-05-01. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.

At TREACE MEDICAL CONCEPTS INC.'s shareholder meeting held 2024-05-21, in the 2023-2024 proxy season, 162 asset managers reported how they voted in their SEC Form N-PX filings, covering 1,246 separate fund positions. Their filings are grouped here into 8 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — Approval, on an advisory, non- binding basis, of the compensation of the Company's named… — FOR was 92% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: TREACE MEDICAL CONCEPTS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2024-05-22.

TREACE MEDICAL CONCEPTS INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.